Revelation Biosciences (REVB) Short Interest Ratio & Short Volume $2.70 -0.06 (-2.17%) Closing price 04:00 PM EasternExtended Trading$2.66 -0.05 (-1.67%) As of 05:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Revelation Biosciences Short Interest DataRevelation Biosciences (REVB) has a short interest of 243,600 shares, representing 14.33% of the float (the number of shares available for trading by the public). This marks a -8.49% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 213,357 shares to cover all short positions.Current Short Interest243,600 sharesPrevious Short Interest266,200 sharesChange Vs. Previous Month-8.49%Dollar Volume Sold Short$628.49 thousandShort Interest Ratio0.5 Days to CoverLast Record DateAugust 15, 2025Outstanding Shares1,700,000 sharesFloat Size1,700,000 sharesShort Percent of Float14.33%Today's Trading Volume45,951 sharesAverage Trading Volume213,357 sharesToday's Volume Vs. Average22% Short Selling Revelation Biosciences? Sign up to receive the latest short interest report for Revelation Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartREVB Short Interest Over TimeREVB Days to Cover Over TimeREVB Percentage of Float Shorted Over Time Revelation Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/2025243,600 shares $628.49 thousand -8.5%14.3%0.5 $2.58 7/31/2025266,200 shares $662.84 thousand +27.0%17.4%0.6 $2.49 7/15/2025209,600 shares $601.55 thousand +831.6%13.7%0.5 $2.87 6/30/202522,500 shares $50.63 thousand -85.3%3.3%0.1 $2.25 6/15/2025153,000 shares $121.48 thousand +11.0%7.5%0.2 $0.79 5/31/2025137,900 shares $117.61 thousand +229.9%8.4%0.1 $0.85 5/15/202541,800 shares $126.65 thousand -39.9%4.3%0.4 $3.03 4/30/202569,600 shares $212.28 thousand -41.3%7.2%0.6 $3.05 4/15/2025118,500 shares $361.43 thousand +131.0%13.1%0.8 $3.05 3/31/202551,300 shares $134.92 thousand +118.3%5.7%0.3 $2.63 Get the Latest News and Ratings for REVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Revelation Biosciences and its competitors with MarketBeat's FREE daily newsletter. 3/15/202523,500 shares $79.90 thousand -61.9%2.6%0.1 $3.40 2/28/202561,700 shares $215.33 thousand -31.1%6.8%0.3 $3.49 2/15/202589,500 shares $383.06 thousand +41.2%17.1%0.4 $4.28 1/31/202563,400 shares $239.02 thousand +38.1%12.1%0.3 $3.77 1/15/202545,900 shares $359.86 thousand -80.9%0.6%0.2 $7.84 12/31/2024240,400 shares $110.82 thousand +450.1%2.9%0.1 $0.46 12/15/202443,700 shares $15.73 thousand -65.3%0.5%0 $0.36 11/30/2024125,800 shares $95.61 thousand -70.7%2.0%0.1 $0.76 11/15/2024428,600 shares $344.17 thousand +937.8%10.0%0.8 $0.80 10/31/202441,300 shares $35.23 thousand +81.1%1.1%0 $0.85 10/15/202422,800 shares $17.78 thousand -59.7%0.6%0 $0.78 9/30/202456,600 shares $48.21 thousand +120.2%1.5%0 $0.85 9/15/202425,700 shares $23.10 thousand -78.7%0.7%0 $0.90 8/31/2024120,400 shares $138.46 thousand -61.6%7.3%0.1 $1.15 8/15/2024313,700 shares $280.89 thousand +645.1%19.1%0.2 $0.90 7/31/202442,100 shares $69.47 thousand -10.6%2.6%0.1 $1.65 7/15/202447,100 shares $88.08 thousand -44.3%2.9%0.1 $1.87 6/30/202484,500 shares $161.40 thousand +128.4%5.2%0.1 $1.91 6/15/202437,000 shares $81.77 thousand +68.2%2.3%0.1 $2.21 5/31/202422,000 shares $41.14 thousand -11.3%1.4%0.3 $1.87 5/15/202424,800 shares $48.36 thousand +40.1%1.5%0.2 $1.95 4/30/202417,700 shares $37.30 thousand -4.3%1.1%0.1 $2.11 4/15/202418,500 shares $33.76 thousand -43.6%1.1%0 $1.83 3/31/202432,800 shares $89.87 thousand No Change8.3%0.1 $2.74 3/15/202432,800 shares $79.05 thousand -31.5%8.3%0.1 $2.41 2/29/202447,900 shares $174.84 thousand +32.7%12.3%0.1 $3.65 2/15/202436,100 shares $109.02 thousand -70.0%9.2%0.1 $3.02 1/31/2024120,200 shares $1.06 million +526.0%30.8%0.6 $8.80 1/15/2024577,000 shares $8.20 million +27.7%9.3%5.8 $14.22 12/31/2023451,700 shares $226.17 thousand +4.7%7.3%6.7 $0.50Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again. 12/15/2023431,400 shares $237.70 thousand +1,878.9%7.0%7.2 $0.55 11/30/202321,800 shares $15.76 thousand -29.5%0.4%0.4 $0.72 11/15/202330,900 shares $19.48 thousand +134.1%0.5%0.6 $0.63 10/31/202313,200 shares $7.93 thousand -50.6%0.2%0.2 $0.60 10/15/202326,700 shares $18.21 thousand +69.0%0.4%0.4 $0.68 9/30/202315,800 shares $10.89 thousand +79.6%0.3%0.2 $0.69 9/15/20238,800 shares $6.69 thousand +27.5%0.1%0.1 $0.76 8/31/20236,900 shares $4.64 thousand -11.5%0.1%0.1 $0.67 8/15/20237,800 shares $5.59 thousand +14.7%0.1%0.1 $0.72 7/31/20236,800 shares $5.58 thousand -26.9%0.1%0 $0.82 7/15/20239,300 shares $7.79 thousand -35.9%0.2%0 $0.84 6/30/202314,500 shares $13.74 thousand -74.6%0.3%0 $0.95 6/15/202357,000 shares $63.27 thousand -39.8%1.0%0.1 $1.11 5/31/202394,700 shares $99.44 thousand +38.5%1.6%0.1 $1.05 5/15/202368,400 shares $77.29 thousand -26.8%1.2%0.1 $1.13 4/30/202393,400 shares $100.87 thousand -44.9%2.2%0.1 $1.08 REVB Short Interest - Frequently Asked Questions What is Revelation Biosciences' current short interest? Short interest is the volume of Revelation Biosciences shares that have been sold short but have not yet been covered or closed out. As of August 15th, investors have sold 243,600 shares of REVB short. 14.33% of Revelation Biosciences' shares are currently sold short. Learn More on Revelation Biosciences' current short interest. What is a good short interest percentage for Revelation Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.33% of Revelation Biosciences' floating shares are currently sold short. Is Revelation Biosciences' short interest increasing or decreasing? Revelation Biosciences saw a decline in short interest during the month of August. As of August 15th, there was short interest totaling 243,600 shares, a decline of 8.5% from the previous total of 266,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Revelation Biosciences' float size? Revelation Biosciences currently has issued a total of 1,700,000 shares. Some of Revelation Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Revelation Biosciences currently has a public float of 1,700,000 shares. How does Revelation Biosciences' short interest compare to its competitors? 14.33% of Revelation Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Revelation Biosciences: 180 Life Sciences Corp. (30.55%), Ainos, Inc. (8.74%), Synlogic, Inc. (0.55%), Edesa Biotech, Inc. (0.13%), Moleculin Biotech, Inc. (11.94%), Mannatech, Incorporated (1.43%), Cyclacel Pharmaceuticals, Inc. (4.07%), LakeShore Biopharma Co., Ltd. (0.63%), Hoth Therapeutics, Inc. (1.94%), Lipocine Inc. (1.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short Revelation Biosciences stock? Short selling REVB is an investing strategy that aims to generate trading profit from Revelation Biosciences as its price is falling. REVB shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Revelation Biosciences? A short squeeze for Revelation Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of REVB, which in turn drives the price of the stock up even further. How often is Revelation Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REVB, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies ATNF Short Interest AIMD Short Interest SYBX Short Interest EDSA Short Interest MBRX Short Interest MTEX Short Interest CYCC Short Interest LSB Short Interest HOTH Short Interest LPCN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:REVB) was last updated on 9/2/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revelation Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
